TMBIM4 and neoplasm: Conversely, weak proliferating cells, including granulomatous neurons of the cerebellum, even those that are rich in S1R positions, show no sensitivity to the S1R antagonist 1-(4-iodophenyl)-3-(2-adamantyl) guanidine (IPAG), unlike the highly proliferating tumor cells [62].